Objective-Cholesteryl ester transfer protein (CETP) is a target gene for the liver X receptor (LXR). The aim of this study was to further explore this regulation in the monocyte-macrophage lineage and its modulation by lipid loading and inflammation, which are key steps in the process of atherogenesis. Methods and Results-Exposure of bone marrow-derived macrophages from human CETP transgenic mice to the T0901317 LXR agonist increased CETP, PLTP, and ABCA1 mRNA levels. T0901317 also markedly increased CETP mRNA levels and CETP production in human differentiated macrophages, whereas it had no effect on CETP expression in human peripheral blood monocytes. In inflammatory mouse and human macrophages, LXR-mediated CETP gene upregulation was inhibited, even though ABCA1, ABCG1, and SREBP1c inductions were maintained. The inhibition of CETP gene response to LXR agonists in inflammatory cells was independent of lipid loading (ie, oxidized LDL increased CETP production in noninflammatory macrophages with a synergistic effect of synthetic LXR agonists). Conclusion-LXR-mediated induction of human CETP expression is switched on during monocyte-to-macrophage differentiation, is magnified by lipid loading, and is selectively lost in inflammatory macrophages, which suggests that inflammatory cells may not increase the circulating CETP pool on LXR agonist treatment. Key Words: liver X receptor Ⅲ cholesteryl ester transfer protein Ⅲ macrophage Ⅲ monocyte Ⅲ inflammation M acrophages play a central role in the formation of atherosclerotic lesions. These cells produce the cholesteryl ester transfer protein (CETP), which accounts for the enrichment of circulating apoB-containing lipoproteins with cholesteryl esters, but can also contribute to reverse cholesterol transport. 1 As shown by bone marrow transplantation experiments in mice, macrophages, including liver macrophages (Kuppfer cells), contribute significantly to plasma CETP and PLTP pools. 2-5 CETP mRNA was identified mainly in nonparenchymal sinusoidal cells of the liver in cynomolgus monkeys. 6 In humans, cholesterol transfer activity was observed in the culture supernatant of human macrophages, 7,8 and CETP was localized in macrophagederived foam cells by immunohistochemistry or in situ hybridization analysis of atherosclerotic lesions. 9,10 CETP produced in the vicinity of the vascular bed may prevent cholesterol accumulation in lesion macrophages, 9,11 an event involved in both early and late stages of the disease. 12 However, under unfavorable conditions (eg, when apoB-containing lipoprotein clearance is defective), the deleterious effect of systemic CETP could overcome this local beneficial effect. Accordingly, hyperlipidemic LDLr-KO mice transplanted with CETP transgenic (CETPTg) bone marrow cells display a proatherogenic plasma lipoprotein profile and accelerated development of atherosclerotic lesions. 2 The CETP gene promoter can be transactivated in vitro and in vivo by liver X receptors (LXR). 13,14 These oxysterol-activated nuclear receptors interact with a DR4...